http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0460065-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_692dc75829481c48c017b52f352e2bad
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-23
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-02
filingDate 1990-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fdb53055a4d044c02e2a734512369ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc97857a66c14758f3a5cda05ecc8855
publicationDate 1994-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0460065-B1
titleOfInvention A process for the generation of proliferating cd4 lymphocytes
abstract Peripheral blood mononuclear cells (PBMC) or tumor infiltrating lymphocytes (TIL) are treated with a dipeptide alkyl ester such as leucyl leucine methyl ester (LLME) or with an amino acid alkyl ester such as leucine methyl ester (LME) to deplete monocytes and large granular lymphocytes, then cultured in media containing T-cell stimulant and interleukin-2 to generate and proliferate a lymphocyte population enriched in CD4<+> lymphocytes.
priorityDate 1989-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129079762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227644794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231804574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226456292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226554771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID410817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129158105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87990263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44630569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129519306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226586609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61160581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5159380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128037228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232149704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226438903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID736234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226454641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127415666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7016877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226454640

Total number of triples: 49.